Does PIMAVANSERIN Cause Product distribution issue? 134 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Product distribution issue have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.3% of all adverse event reports for PIMAVANSERIN.
134
Reports of Product distribution issue with PIMAVANSERIN
0.3%
of all PIMAVANSERIN reports
1
Deaths
7
Hospitalizations
How Dangerous Is Product distribution issue From PIMAVANSERIN?
Of the 134 reports, 1 (0.7%) resulted in death, 7 (5.2%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
TEDUGLUTIDE (132)
HUMAN C1-ESTERASE INHIBITOR (107)
Which PIMAVANSERIN Alternatives Have Lower Product distribution issue Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE